https://au.news.yahoo.com/trending-today-business-series-airing-140000798.html
Watch to learn how Imugene, a clinical stage immune-oncology company, develops a range of new treatments that seek to activate the immune system of cancer patients to identify and eradicate tumors. By developing cancer immunotherapies and transformative cancer medicines, Imugene seeks to bring effective new treatments and options to patients who need them. Imugene utilizes their unique platform technology to harness and promote the body's immune system against cancerous tumors. Currently, Imugene's product pipeline includes Oncolytic Viruses and B-Cell Immunotherapies aimed at treating a variety of cancers in combination with standard of care drugs and immunotherapies
https://au.news.yahoo.com/trending-today-business-series-airing-1...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.7¢ |
Change
0.001(1.79%) |
Mkt cap ! $418.9M | |||
| Open | High | Low | Value | Volume |
| 5.6¢ | 5.7¢ | 5.4¢ | $461.9K | 8.347M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 1082545 | 5.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.7¢ | 603058 | 6 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |